Orally administrative melk (maternal embryonic leucine zipper kinase)-targeting small molecule inhibitor suppresses the growth of various types of human cancer.
Suyoun Chung
No relevant relationships to disclose
Hanae Suzuki
Employment or Leadership Position - OncoTherapy Science
Takashi Miyamoto
Employment or Leadership Position - OncoTherapy Science
Naofumi Takamatsu
Employment or Leadership Position - OncoTherapy Science
Ayako Tatsuguchi
No relevant relationships to disclose
Koji Ueda
No relevant relationships to disclose
Kyoko Kijima
Employment or Leadership Position - OncoTherapy Science
Yo Matsuo
Employment or Leadership Position - OncoTherapy Science
Yusuke Nakamura
Consultant or Advisory Role - OncoTherapy Science
Stock Ownership - OncoTherapy Science
Research Funding - OncoTherapy Science